Asset Vision Co Limited (ASX:ASV)

Market Cap	27.54M
Revenue (ttm)	4.65M
Net Income (ttm)	257.46K
Shares Out	744.36M
EPS (ttm)	0.00
PE Ratio	127.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,000
Average Volume	140,657
Open	0.0370
Previous Close	0.0370
Day's Range	0.0370 - 0.0370
52-Week Range	0.0170 - 0.0460
Beta	1.09
RSI	50.49
Earnings Date	Aug 29, 2025

About Oncternal Therapeutics

Asset Vision Co Limited provides enterprise asset management solutions to public sector and enterprise in Australia and internationally. It offers Asset Vision Enterprise Platform that streamlines enterprise asset management with integrated web and mobile solutions from predictive modeling to field inspections; Asset Vision CoPilot, which undertakes road inspections and records defects; and Asset Vision AutoPilot that captures a digital twin and identifies road defects using AI technology. The company was formerly known as Future First Technolo...

• Industry: Information Technology Services
• Sector: Technology
• Founded: 2013
• Employees: 305
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ASV

Financial Performance

In 2024, Asset Vision Co's revenue was 4.09 million, an increase of 11.29% compared to the previous year's 3.67 million. Losses were -55,208, -99.36% less than in 2023.